Effect of nitrous oxide on desflurane MACBAR at two target-controlled concentrations of remifentanil

Minerva Anestesiologica

Volumn 74, Issue 5, 2008, Pages 165-172

  Dedola, E ^a   Albertin, A ^b   Poli, D ^a   La Colla, L ^a   Gandolfi, A ^a   Martani, C ^a   Torri, G ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b IRCCS MULTIMEDICA   (Italy)

Author keywords

Desflurane; Nitric oxide; Remifentanil; Sympathetic nervous system

Indexed keywords

CISATRACURIUM; DESFLURANE; NITROUS OXIDE; OXYGEN; PROPOFOL; REMIFENTANIL;

ABDOMINAL SURGERY; ADRENERGIC SYSTEM; ADULT; ANESTHESIA INDUCTION; ARTICLE; ARTIFICIAL VENTILATION; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONFIDENCE INTERVAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ELECTIVE SURGERY; FEMALE; GENERAL ANESTHESIA; HUMAN; MAJOR CLINICAL STUDY; MALE; MINIMUM LUNG ALVEOLUS CONCENTRATION; MONOTHERAPY; POSTOPERATIVE PERIOD; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE;

ADULT; ANESTHETICS, INHALATION; ANESTHETICS, INTRAVENOUS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; ISOFLURANE; MALE; MIDDLE AGED; NITROUS OXIDE; PIPERIDINES; PROSPECTIVE STUDIES; SYMPATHETIC NERVOUS SYSTEM;

EID: 46049101432     PISSN: 03759393     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Zbinden AM, Petersen-Felix S, Thomson DA. Anesthetic depth defined using multiple noxious stimuli during isoflurane/oxygen anesthesia: II. Hemodynamic responses. Anesthesiology 1994;80:261-7.
2. Katoh T, Ikeda K. The effects of fentanyl on sevoflurane requirements for loss of consciousness and skin incision. Anesthesiology 1998;88:18-24.
3. Daniel M, Weiskopf RB, Noorani M, Eger EI. Fentanyl augments the blockade of the sympathetic response to incision (MAC-BAR) produced by desflurane and isoflurane: Desflurane and isoflurane MAC-BAR without and with fentanyl. Anesthesiology 1998;88:43-9.
4. Katoh T, Kobayashi S, Suzuki A, Iwamoto T, Bito H, Ikeda K. The effects of fentanyl on sevoflurane requirements for somatic and sympathetic responses to surgical incision. Anesthesiology 1999;90:398-405.
5. Katoh T, Nakajima Y, Moriwaki G, Kobayashi S, Suzuki A, Iwamoto T et al. Sevoflurane requirements for tracheal intubation with and without fentanyl. Br J Anesth 1999;82: 561-5.
6. Glass PSA, Hardman D, Kamiyama Y, Quill TJ, Marton G, Donn KH et al. Preliminary pharmacokinetics and pharmacodynamics of an ultra-short-acting opioid: Remifentanil (GI87084B). Anesth Analg 1993;77:1031-40.
7. Albertin A, Casati A, Deni F, Danelli G, Comotti L, Grifoni F et al. Clinical comparison of either small doses of fentanyl or remifentanil for blunting cardiovascular changes induced by tracheal intubation. Minerva Anestesiol 2000;66:691-6.
8. Casati A, Albertin A, Fanelli G, Deni F, Berti M, Danelli G et al. A comparison of remifentanil and sufentanil as adjuvants during sevoflurane anesthesia with epidural analgesia for upper abdominal surgery: Effects on postoperative recovery and respiratory function. Anesth Analg 2000;91:1269-73.
9. Matute E, Alsina E, Roses R, Blanc G, Perez-Hernandez C, Gilsanz F. An inhalation bolus of sevoflurane versus an intravenous bolus of remifentanil for controlling hemodynamic responses to surgical stress during major surgery: A prospective randomized trial. Anesth Analg 2002;94:1217-22.
10. De Castro V, Godet G, Mencia G, Raux M, Coriat P. Target-controlled infusion for remifentanil in vascular patients improves hemodynamics and decreases remifentanil requirement. Anesth Analg 2003;96:33-8.
11. Glass PS, Glen JB, Kenny GN, Schuttler J, Shafer SL. Nomenclature for computer-assisted infusion devices. Anesthesiology 1997;86:1430-1.
12. Minto CF, Schnider TW, Egan TD, Youngs E, Lemmens HJM, Gambus PL et al. Influence of age and gender on the pharmacokinetics and pharmacodynamics of remifentanil: I. Model development. Anesthesiology 1997;86:10-23.
13. Minto CF, Schnider TW, Shafer SL. Pharmacokinetics and pharmacodynamics of remifentanil: II. Model application. Anesthesiology 1997;86:24-33.
14. Nakata Y, Goto T, Ishiguro Y, Terui K, Niimi Y, Morita S. Anesthetic doses of sevoflurane to block cardiovascular responses to incision when administered with xenon or nitrous oxide. Anesthesiology 1999;91:369-73.
15. Dixon JW. Staircase bioassay: The up-and-down method. Neurosci Biobehavioral Rev 1991;15:47-50.
16. Katoh T, Ikeda K. The minimum alveolar anesthetic concentration (MAC) of sevoflurane in humans. Anesthesiology 1987;66:301-3.
17. Wetherill GB. Sequential estimation of quantal response curves. J R Stat Soc 1963;B25:1-48.
18. Choi SC. Interval estimation of the LD50 based on an up-and-down experiment. Biometrics 1990;46:485-92.
19. Jung H, Choi SC. Sequential method of estimating the LD50 using a modified up-and-down rule. J Biopharm Stat 1994;4:19-30.
20. Roizen MF, Horrigan RW, Frazer BM. Anesthetic doses blocking adrenergic (stress) and cardiovascular responses to incision: MAC BAR. Anesthesiology 1981;54:390-8.
21. Eger EI. Age, minimum alveolar anesthetic concentration, and minimum alveolar anesthetic concentration-awake. Anesth Analg 2001;93:947-53.
22. Albertin A, Casati A, Bergonzi P, Fano G, Torri G. Effects of two target-controlled concentrations (1 and 3 ng/ml) of remifentanil on MAC(BAR) of sevoflurane. Anesthesiology 2004;100:255-9.
23. Schneider G, Sebel PS: Monitoring depth of anaesthesia. Eur J Anaesthesiol 1997;15 (Suppl):21-8.
24. Shafer A, Doze VA, Shafer SL, White PF. Pharmacokinetics and pharmacodynamics of propofol infusions during general anesthesia. Anesthesiology 1988;69:348-56.
25. Westmoreland CL, Hoke JF, Sebel PS, Hug CC Jr., Muir KT. Pharmacokinetics of remifentanil (GI87084B) and its major metabolite (GI90291) in patients undergoing elective inpatient surgery. Anesthesiology 1993;79:893-903.
26. Mertens MJ, Engbers FHM, Burm AGL, Vuyk J. Predictive performance of computer-controlled infusion of remifentanil during propofol/ remifentanil anaesthesia. Br J Anaesth 2003;90:132-41.
27. Albertin A., Dedola E., Bergonzi PC, Lombardo F, Fusco T, Torri G. The effect of adding two target-controlled concentrations (1-3 ng/mL) of remifentanil on MACBAR of desflurane. Eur J Anaesth 2006;23:510-6.